Orin Hirschman, Director at Ohr Pharmaceutical Inc (OHRP), bought 142,858 shares at $0.70 ($100K) on 2017-04-10, disclosed to the SEC on 2017-04-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.